Seal the Deal Endowment Fund

Raymond Dannenhoffer, PhD ’87 and Mary Anne Dannenhoffer, PharmD ’87.

This fund is designed to help recruit and retain outstanding students who bring diversity to their class and to the medical school.

The Seal the Deal Endowment Fund is used to enable top students to say “yes” to UB when it might not otherwise be possible, or to stay in school when outside obligations might prevent them from staying through to graduation. The fund was established by Raymond P. Dannenhoffer, Ph.D., '87, M.A., '82.

Specifically, this fund helps UB recruit and retain students in situations where attending UB might otherwise be difficult. For example, the fund can be used for students who have a financial obligation to support a family member, or need assistance paying for childcare.

By providing financial assistance, the fund assists in recruiting and retaining outstanding students, including minority students, those who have immigrated to the United States or are children of immigrants, those who are first in their family to attend college and medical school, as well as economically challenged and disadvantaged students from underserved areas. In this way, the fund helps bring diversity to their class and to the School as a whole.

Other Jacobs School of Medicine and Biomedical Sciences Funds

News from the Jacobs School of Medicine and Biomedical Sciences

  • Biotech Venture Wins UB Entrepreneurship Contest
    11/6/20

    Jacobs School of Medicine and Biomedical Sciences students and alumnae are among the members of the top two teams in this year’s University at Buffalo’s Henry A. Panasci Jr. Technology Entrepreneurship Competition (Panasci TEC).

  • Match Day 2020
    3/20/20

    Medical students in the University at Buffalo’s Class of 2020 learned where they will train in residency at Match Day, a rite of passage for prospective physicians.

  • Mature Human Cells Produced in Millions in Mouse Embryo
    7/23/20

    Researchers at the Jacobs School of Medicine and Biomedical Sciences have developed a method that dramatically ramps up production of mature human cells in mouse embryos.

  • Cain Named to Regional Panel Monitoring COVID-19
    6/4/20

    Michael E. Cain, MD, vice president for health sciences and dean of the Jacobs School of Medicine and Biomedical Sciences, has been appointed to serve on the Western New York Control Room, which monitors statistics related to COVID-19 in the region.

  • Jacobs School Responds to Killing of George Floyd
    6/9/20

    Trainees, faculty and administrators of the Jacobs School of Medicine and Biomedical Sciences and the units in the Academic Health Center (AHC) are responding to the police killing of George Floyd and the international protests it has engendered against the backdrop of the COVID-19 pandemic.

  • B Cell Stimulation in COVID-19 Infections Clinical Study Focus
    4/8/20

    Mark D. Hicar, MD, PhD, assistant professor of pediatrics, is leading a clinical study that investigates why the novel coronavirus is so potentially devastating for adults but well tolerated in most children.

  • Faculty Members Note Link Between COVID-19 and Stroke
    5/12/20

    Faculty members at the Jacobs School of Medicine and Biomedical Sciences are working collaboratively with doctors throughout the U.S. to learn more about a new link they are seeing in some patients between COVID-19 and stroke. And it is occurring in an unexpected population.